Why the study?
The molecular mechanisms by which LMNA mutations drive DCM remain poorly understood, particularly how the p.S143P mutation affects lamin structure, nuclear mechanics, electrophysiological properties, and gene expression.
Population
Patient-derived hiPSC-cardiomyocytes carrying the LMNA p.S143P mutation and healthy control lines
Comparison
Patient-derived p.S143P mutant cardiomyocytes vs healthy control cardiomyocytes
Design
In vitro experimental study of patient-derived hiPSC-cardiomyocytes
Answers are grounded in this paper and cite their sources.
Reveals impaired nuclear mechanics, altered gene expression, and disrupted calcium handling in lamin-mutant cardiomyocytes, highlighting a mechanobiological driver of dilated cardiomyopathy.
Mutations of the LMNA gene are the second most common genetic cause for dilated cardiomyopathy (DCM) and significant cause of non-dilated left ventricular cardiomyopathy (NDLVC). Lamins A and C, both encoded by the LMNA , have a role in maintaining nuclear architecture, DNA replication, transcription, and apoptosis, but the molecular mechanisms by which LMNA mutations drive DCM remain poorly understood. Previous studies have shown that the p.S143P mutation increases mobility and nucleoplasmic pool of lamin A/C, suggesting that it is less tightly bound to the intranuclear elements and to the nuclear envelope. We utilized patient-derived cardiomyocytes (CMs) and investigated the impact of p.S143P mutation on lamin structure, nuclear mechanics, electrophysiological properties, and gene expression to understand the mechanisms linking the mutation to DCM. A dual lamin A/C labeling approach revealed increased N-terminal and decreased rod-domain epitope accessibility of patient line compared to the control line indicating changes in nuclear lamina organization. Fluorescence Resonance Energy Transfer analysis using fluorescent protein-based strain sensor showed a shift in lamin strain towards a relaxed state in patient-derived cardiomyocytes compared with healthy controls. Transcriptomic profiling supported the impact of these results, showing dysregulation of genes involved in cytoskeleton and mechanosensitive pathways. Electrophysiological analysis of CMs revealed increased calcium densities in calcium currents and increased number of delayed after depolarizations in mutant CMs. In conclusion, the findings indicate that the p.S143P LMNA mutation directly disrupts nuclear lamina organization leading to impaired mechanotransduction, alters expression of genes related to cytoskeleton organization and mechanosensation, and perturbs calcium signaling, providing an integrated mechanobiological route to DCM pathogenesis.
No takes yet. Share an insight, caveat, or question.
Kuusela et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: